Cargando…
Role of inflammatory markers in Takayasu arteritis disease monitoring
BACKGROUND: Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis that can result in significant morbidity and mortality secondary to progressive stenosis and occlusion. Monitoring disease progression is crucial to preventing relapse, but is often complicated by the lack of clinical sympt...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012521/ https://www.ncbi.nlm.nih.gov/pubmed/24678735 http://dx.doi.org/10.1186/1471-2377-14-62 |
_version_ | 1782314943169691648 |
---|---|
author | O’Connor, Timothy E Carpenter, Haley E Bidari, Sharatchandra Waters, Michael F Hedna, Vishnumurthy Shushrutha |
author_facet | O’Connor, Timothy E Carpenter, Haley E Bidari, Sharatchandra Waters, Michael F Hedna, Vishnumurthy Shushrutha |
author_sort | O’Connor, Timothy E |
collection | PubMed |
description | BACKGROUND: Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis that can result in significant morbidity and mortality secondary to progressive stenosis and occlusion. Monitoring disease progression is crucial to preventing relapse, but is often complicated by the lack of clinical symptoms in the setting of active disease. Although acute phase reactants such as ESR and CRP are generally used as an indicator of inflammation and disease activity, mounting evidence suggests that these markers cannot reliably distinguish active from inactive TA. CASE PRESENTATION: We report a 24-year-old Hispanic female with a 5-year history of TA who presented with stroke-like symptoms and evidence of left MCA occlusion on imaging, despite a history of decreasing inflammatory markers. CTA revealed complete occlusion of the left common carotid artery, left subclavian, and left MCA from their origins. It also revealed a striking compensatory circulation supplying the left anterior circulation as well as the left subclavian as a response to progressive stenosis. CONCLUSION: Monitoring ESR and CRP levels alone may not be a reliable method to evaluate disease progression in patients with TA, and should be taken in context with both patient’s clinical picture and the imaging. We recommend that serial imaging be performed regularly in the setting of active disease to monitor progression and allow for immediate therapy in response to evidence of disease advancement, with a relaxation of the imaging interval once the disease is presumed inactive. |
format | Online Article Text |
id | pubmed-4012521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40125212014-05-08 Role of inflammatory markers in Takayasu arteritis disease monitoring O’Connor, Timothy E Carpenter, Haley E Bidari, Sharatchandra Waters, Michael F Hedna, Vishnumurthy Shushrutha BMC Neurol Case Report BACKGROUND: Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis that can result in significant morbidity and mortality secondary to progressive stenosis and occlusion. Monitoring disease progression is crucial to preventing relapse, but is often complicated by the lack of clinical symptoms in the setting of active disease. Although acute phase reactants such as ESR and CRP are generally used as an indicator of inflammation and disease activity, mounting evidence suggests that these markers cannot reliably distinguish active from inactive TA. CASE PRESENTATION: We report a 24-year-old Hispanic female with a 5-year history of TA who presented with stroke-like symptoms and evidence of left MCA occlusion on imaging, despite a history of decreasing inflammatory markers. CTA revealed complete occlusion of the left common carotid artery, left subclavian, and left MCA from their origins. It also revealed a striking compensatory circulation supplying the left anterior circulation as well as the left subclavian as a response to progressive stenosis. CONCLUSION: Monitoring ESR and CRP levels alone may not be a reliable method to evaluate disease progression in patients with TA, and should be taken in context with both patient’s clinical picture and the imaging. We recommend that serial imaging be performed regularly in the setting of active disease to monitor progression and allow for immediate therapy in response to evidence of disease advancement, with a relaxation of the imaging interval once the disease is presumed inactive. BioMed Central 2014-03-28 /pmc/articles/PMC4012521/ /pubmed/24678735 http://dx.doi.org/10.1186/1471-2377-14-62 Text en Copyright © 2014 O¿Connor et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report O’Connor, Timothy E Carpenter, Haley E Bidari, Sharatchandra Waters, Michael F Hedna, Vishnumurthy Shushrutha Role of inflammatory markers in Takayasu arteritis disease monitoring |
title | Role of inflammatory markers in Takayasu arteritis disease monitoring |
title_full | Role of inflammatory markers in Takayasu arteritis disease monitoring |
title_fullStr | Role of inflammatory markers in Takayasu arteritis disease monitoring |
title_full_unstemmed | Role of inflammatory markers in Takayasu arteritis disease monitoring |
title_short | Role of inflammatory markers in Takayasu arteritis disease monitoring |
title_sort | role of inflammatory markers in takayasu arteritis disease monitoring |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012521/ https://www.ncbi.nlm.nih.gov/pubmed/24678735 http://dx.doi.org/10.1186/1471-2377-14-62 |
work_keys_str_mv | AT oconnortimothye roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring AT carpenterhaleye roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring AT bidarisharatchandra roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring AT watersmichaelf roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring AT hednavishnumurthyshushrutha roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring |